Modalis Therapeutics to Present Data Supporting of Development of Transformative Epigenetic Editing Medicines for the Treatment of a Type of Muscular Dystrophy at the ASGCT Annual Meeting
MDL-101 preclinical data support efficacy and safety of a differentiated precision medicine approach for LAMA2…